Doctor profile · Federal record

Dr. David Chin Yee, MD

Retina Specialist (Ophthalmology) Physician (CMS: Ophthalmology) · Ophthalmology Physician · Atlanta, GA

  • NPI 1740424563
  • Accepts Medicare
  • MIPS 86.9 / 100 · 2023
  • 17 yrs in practice
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1100 Johnson Ferry RD, Ste 593
Atlanta, GA 303421709
(404) 255-9096
fax (404) 255-9097

Credentials & registration

NPPES · NUCC
NPI registered
April 2009 — 17 yrs on file
Profile last updated
March 23, 2023
Year of graduation
2009 — 17 yrs since
Specialty taxonomy
207WX0107X — NUCC code
State licenses (2)
Georgia #73205 · Missouri #2013006686

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1740424563. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
48,460
Distinct HCPCS
10
Medicare allowed
$3,726,363
HCPCS Description Services Patients Avg allowed
J2777 Injection, faricimab-svoa, 0.1 mg 38,160 107 $36
92134 Imaging of retina 2,315 840 $40
J2778 Injection, ranibizumab, 0.1 mg 2,308 104 $232
67028 Injection of drug into eye 1,680 357 $121
J0178 Injection, aflibercept, 1 mg 1,224 120 $872
92014 Established patient complete exam of visual system 969 745 $124
J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg 483 20 $199
92250 Photography of the retina 370 270 $37
92012 Established patient problem focused exam of visual system 341 226 $89
J2781 Injection, pegcetacoplan, intravitreal, 1 mg 255 13 $151

In context: peer comparison

Among 2 peers in this city , average services per provider: 1,934. This provider delivers 25× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$266,245
Transactions
283
Manufacturers
14
Payer (manufacturer) Industry Txns Amount
Regeneron Healthcare Solutions, Inc. 76 $95,395.94
Astellas Pharma US Inc 65 $61,803.49
Apellis Pharmaceuticals, Inc. 57 $51,778.81
Genentech USA, Inc. 31 $29,154.10
Regeneron Pharmaceuticals, Inc. 13 $12,228.24
Alimera Sciences, Inc. 13 $7,095.79
F. Hoffmann-La Roche AG 2 $4,572.16
EyePoint Pharmaceuticals US, Inc. 10 $3,520.47
Bausch & Lomb Americas Inc. 7 $398.50
Biogen, Inc. 3 $161.22
ABBVIE INC. 3 $58.87
Sandoz Inc. 1 $36.76
ANI Pharmaceuticals, Inc. 1 $25.16
Astellas Pharma Global Development 1 $15.51

By nature of payment

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
$176,625
Consulting Fee
$36,867
Travel and Lodging
$29,502
Honoraria
$17,146
Food and Beverage
$6,105

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
636
Patients
328
Total drug cost
$36,311
Drug Type Claims Patients Total cost
Prednisolone Acetate Generic 123 87 $7,448
Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) Brand 79 37 $1,453
Brimonidine Tartrate Generic 72 29 $2,012
Timolol Maleate Generic 60 23 $1,790
Ciprofloxacin Hcl Generic 50 45 $613
Latanoprost Generic 50 17 $760
Atropine Sulfate Generic 48 39 $2,327
Ketorolac Tromethamine Generic 45 24 $1,648
Dorzolamide Hcl Generic 31 15 $395
Prolensa (Bromfenac Sodium) Brand 29 12 $9,895

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. David Chin Yee's medical specialty?
Dr. David Chin Yee practices Retina Specialist (Ophthalmology) Physician in Atlanta, GA.
Where does Dr. David Chin Yee practice?
Dr. David Chin Yee practices at 1100 Johnson Ferry RD, Atlanta, GA 303421709. Office phone: 4042559096.
What is Dr. David Chin Yee's NPI?
Dr. David Chin Yee's National Provider Identifier (NPI) is 1740424563, issued by NPPES.
Does Dr. David Chin Yee accept Medicare assignment?
Yes. Dr. David Chin Yee accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. David Chin Yee commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Imaging of retina (HCPCS 92134); Injection, ranibizumab, 0.1 mg (HCPCS J2778). Source: CMS Medicare Physician & Other Practitioners file.